Puma Biotechnology to present its abstract at ESMO 2017

ME PubManu Team

Puma Biotechnology, Inc., a biopharmaceutical company announces the release of two abstracts on its drug neratinib. It will be presented at the European Society for Medical Oncology (ESMO) 2017 Congress, which is to be held from September 8 – 12 in Madrid, Spain.

Reference Link: http://markets.businessinsider.com/news/stocks/puma-biotechnology-announces-publication-of-abstracts-for-esmo-2017-1002296389

Related Posts

IEEE lifts ban on Huawei scientist reviewers

Amidst the U.S. – China trade war, IEEE recently banned employees of Huawei from vetting submission to its technical papers because of U.S. sanctions against the company. According to the new law, Huawei scientist can indulge in IEEE sponsored conferences, make presentations and submit articles to IEEE but won’t be given access to handle any […]

Flexible and powerful against cancer

Connecting restoratively dynamic atoms to particular antibodies can pilot them to their assigned targets and limit reactions – particularly while treating tumors. Researchers have now portrayed novel conjugates produced using antibodies and a kinesin axle protein inhibitor. Changing the linker between the two parts takes into consideration tuning the movement of this cytostatic sedate, which […]

New Study Identifies Regions Most Vulnerable to Extreme Heat

New research led by the University of Bristol has highlighted regions across the world most at risk of devastating effects from unprecedented heat waves. The study identifies regions such as Afghanistan, Papua New Guinea, Central America, Beijing, and Central Europe as the most vulnerable due to socioeconomic vulnerability and limited adaptation measures. The researchers used […]

Leave a Reply

Your email address will not be published. Required fields are marked *